Powder: -20°C for 3 years | In solvent: -80°C for 1 year
α-Glucosidase-IN-30 (compound 8c) is a potent, orally active competitive inhibitor of α-glucosidase, exhibiting a K i of 40.0 µM and an IC50 of 49.0 µM. It is non-cytotoxic to both cancerous MCF-7 and normal HDF cell lines, rendering it suitable for Type 2 diabetes research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | α-Glucosidase-IN-30 (compound 8c) is a potent, orally active competitive inhibitor of α-glucosidase, exhibiting a K i of 40.0 µM and an IC50 of 49.0 µM. It is non-cytotoxic to both cancerous MCF-7 and normal HDF cell lines, rendering it suitable for Type 2 diabetes research [1]. |
In vitro | Compound 8c, referred to as α-Glucosidase-IN-30, exhibits no cytotoxic activity against the MCF-7 and HDF cell lines, with IC50 values exceeding 200 μM [1]. |
Molecular Weight | 389.41 |
Formula | C20H19N7O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
α-Glucosidase-IN-30 Metabolism Glucosidase inhibitor inhibit